Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction
暂无分享,去创建一个
Andrew Simon Bell | N. Terrett | A. Bell | Nicholas K. Terrett | David Dr. Brown | Peter M. Ellis | P. Ellis | D. Brown | David Brown | A. Bell
[1] S. Snyder,et al. Nitric oxide: a physiologic mediator of penile erection. , 1992, Science.
[2] I. Goldstein,et al. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. , 1991, The Journal of clinical investigation.
[3] C. Lugnier,et al. Endothelium‐dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors , 1991, British journal of pharmacology.
[4] L. Ignarro,et al. Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission , 1992 .
[5] K. James,et al. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. , 1989, Biochemical and biophysical research communications.
[6] P. J. England,et al. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents. , 1992, Biochemical Society transactions.
[7] R. B. Wilson,et al. Antiallergenic 8-azapurines. 3. Structural characterization of 2-(2-propoxyphenyl)-8-azahypoxanthine, 2-[2-propoxy-5-(propylsulfonyl)phenyl]-8-azahypoxanthine, and 2-[2-propoxy-5-(N-methyl-N-isopropylsulfamoyl)phenyl]-8-azahypoxanthine , 1982 .
[8] J. Beavo,et al. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.
[9] P. Canniff,et al. Comparative hemodynamic and renal effects of the low Km cGMP phosphodiesterase inhibitors cicletanine and zaprinast in anesthetized dogs , 1991 .
[10] J. Beavo,et al. Multiple cyclic nucleotide phosphodiesterases. , 1994, Molecular pharmacology.